Mandy Jackson, PharmD

Executive Medical Science Liaison, Medical Affairs
AstraZeneca

Poster(s):

• (408) Reduction in Asthma Exacerbations Following Initiation of Benralizumab Among Medicare Beneficiaries: Results from the ZEPHYR-5 Study
  Wednesday, October 29, 2025